Increasing Inclination of Oncologists and Physician to opt for Non-Invasive Diagnostic Procedures is Anticipated to Propel the Growth of the Global Liquid Biopsy market
The Global Liquid Biopsy market is anticipated to upsurge at a high rate owing to the factors such as rising consumption of alcohol and tobacco products, increasing prevalence of cancer cases along with burgeoning preference for non-invasive procedures and escalating funding for liquid biopsy research and development. Moreover, snowballing funding by public and private companies to support research activities, surge in the clinical trials for the development of these tests coupled with robust changing lifestyle of people and increasing inclination of oncologists and physician to opt for non-invasive diagnostic procedures are projected to fuel the growth of the market in the forthcoming years.
The COVID-19 pandemic has positive impact on the liquid biopsy market as it surged the demand for liquid biopsy test as it used to improve cancer screening along with introduction of commercialize saliva-based liquid biopsy tests for head and neck cancer, COVID-19. .
Get a sample copy of the Liquid Biopsy Market Analysis Report at: https://www.marknteladvisors.com/query/request-sample/global-liquid-biopsy-market.html
North America acquired the majority market share in the Liquid Biopsy market in 2020. US dominated the North America region. The growth is attributed to owing to increasing incidences of cancer, along with significant growth in pre-screening program for cancer detection and burgeoning awareness among people regarding minimal invasive methods. Moreover, burgeoning government investment in the healthcare infrastructure, escalating demand for non-invasive treatment and surging funding on research on cancer biomarkers are strongly contributing toward the growth of the market in the coming years.
The key players with a considerable market share in the Global Liquid Biopsy market are Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.
Comments
Post a Comment